Bone News and Research

RSS

Shire publishes efficacy study results of FOSRENOL and Renagel

Shire plc, the global specialty biopharmaceutical company, today announces the publication in Clinical Nephrology of findings from a head-to-head clinical study comparing the efficacy of two non-calcium based phosphate binders, FOSRENOL(R) (lanthanum carbonate) and sevelamer hydrochloride (Genzyme's Renagel(R)) in chronic kidney disease (CKD) patients on haemodialysis.

7 Oct 2009

The Top 10 Medical Innovations for 2010 announced at Cleveland Clinic Medical Innovation Summit

Cleveland Clinic's Top 10 Medical Innovations for 2010 list features a wide range of new techniques and therapies that are being developed to treat everything from deafness and Parkinson's disease to pneumonia and sleep disorders.

7 Oct 2009

Patients and surgeons drive demand for elective orthopedic procedures despite economic slowdown

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, patients and surgeons are driving demand for elective orthopedic procedures.

7 Oct 2009

CML Healthcare Income Fund to acquire two medical imaging operations

CML HealthCare Income Fund (the "Fund" or "CML HealthCare"), (TSX: CLC.UN) today announced that its operating subsidiary, CML HealthCare Inc. ("CML") has entered into definitive agreements to acquire two medical imaging operations comprising six centers located in the Northeast United States.

7 Oct 2009

Galapagos receives EUR 500,000 cash payment from GSK

Galapagos NV (Euronext: GLPG) announced today that it has reached the first milestone in its antibacterials and antivirals alliance with GlaxoSmithKline (GSK). For achieving this milestone, Galapagos receives a EUR 500,000 cash payment from GSK.

7 Oct 2009

Daily doses of imatinib mesylate double survival rates in Ph+ ALL affected children

Results of a phase two clinical trial published October 5th in the Journal of Clinical Oncology show that adding continuous daily doses of a targeted drug called imatinib mesylate to regular chemotherapy more than doubled three-year survival rates for children with a high risk type of blood cancer called Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).

7 Oct 2009

Research to explore diagnosis and treatment of rare diseases

The National Institutes of Health announced today a second phase of the Rare Diseases Clinical Research Network (RDCRN) including funds for 19 research consortia.

7 Oct 2009

NIDCR announces research and technology grants to support new Facebase Consortium

The integration process just got a lot easier. The National Institute of Dental and Craniofacial Research (NIDCR), part of the National Institutes of Health, announced today it has issued the first 11 research and technology grants of its new FaceBase Consortium.

7 Oct 2009

HRT may increase urinary incontinence in postmenopausal women

Grappling with the risks and benefits of hormone replacement therapy (HRT) is nothing new for postmenopausal women. Researchers have now added more fuel to the fire, with evidence that HRT could play a role in incontinence.

7 Oct 2009

Scientists create new technology to improve detection of leukemia cells in bone marrow

Scientists have created a viable technology to improve the detection of leukemia cells in bone marrow.

7 Oct 2009

NIH awards NeoStem a GO grant to investigate the potential of stem cells in regenerating bone

NeoStem, Inc. (NYSE Amex: NBS), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need and holder of the exclusive, worldwide license to VSEL(TM) Technology that uses very small embryonic-like stem cells isolated from peripheral blood, announced today that it has been awarded a grant of $108,746 for the repair of bone defects by human stem cells under the American Recovery and Reinvestment Act (RRA) of 2009 from the National Institute of Arthritis and Musculoskeletal and Skin Disease (NIAMS) of the National Institutes of Health (NIH).

7 Oct 2009

pDCs promote growth and survival of malignant myeloma cells

Multiple myeloma cancer cells thwart many of the drugs used against them by causing nearby cells to turn traitor - to switch from defending the body against disease to shielding the myeloma cells from harm - Dana-Farber Cancer Institute scientists report in the October issue of Cancer Cell.

6 Oct 2009

LMA Stonebreaker and Holmium Lasers to feature at 27th World Congress on Endourology

Continuing to drive innovation in endourology, Cook Medical will feature a series of product demonstrations and interactive presentations with a special emphasis on kidney stone management solutions, including the LMA Stonebreaker and Holmium Lasers at the 27th Annual World Congress on Endourology and SWL (shock wave lithotripsy) at the Sheraton Grand Hotel in Munich, Germany from 6-10 October.

6 Oct 2009

AAOS to participate in "Get Connected" electronic prescribing program

The American Academy of Orthopaedic Surgeons (AAOS) today announced their participation in "Get Connected," a program designed to help more of the nation's physicians and other prescribers use electronic prescribing.

6 Oct 2009

AAAHC accreditation for Laser Spine Institute Tampa

Laser Spine Institute, leaders in minimally invasive spinal surgery, is pleased to announce the accreditation of LSI Tampa by the Accreditation Association for Ambulatory Health Care.

6 Oct 2009

St. Jude Children’s Research Hospital researcher receives the Millipore Guava Flow Cytometry Award

Millipore Corporation, a Life Science leader providing technologies, tools and services for bioscience research and biopharmaceutical manufacturing, today awarded Dr. Mari Hashitate Dallas of St. Jude Children’s Research Hospital in Memphis, Tenn., the Millipore Guava® Flow Cytometry Award.

6 Oct 2009

Spinal fusion dynamic stabilization system manufacturers ordered to conduct postmarket surveillance studies

The U.S. Food and Drug Administration today ordered manufacturers of certain types of pedicle screw systems, called dynamic stabilization systems, to conduct postmarket surveillance studies to collect clinical data on a number of potential safety issues, including fusion rates and frequency of additional surgeries.

6 Oct 2009

Survival rates for multivisceral transplants increase with new treatment strategies

Data from the largest single-center experience of adult and pediatric intestinal and multivisceral transplantation show that survival rates have improved with the advent of innovative surgical techniques, novel immunosuppressive protocols and better post-operative management, said researchers at the Thomas E. Starzl Transplantation Institute in a study published in the October issue of Annals of Surgery.

6 Oct 2009

Winner of 2009 NAMS award

Michael Holick, PhD, MD, director of the Bone Healthcare Clinic and the Vitamin D, Skin and Bone Research Laboratory at Boston University School of Medicine BUSM recently received the 2009 NAMS/Upsher-Smith Laboratories, Inc.Vitamin D Research Award from the North American Menopause Society (NAMS).

6 Oct 2009

Schering-Plough receives FDA recommendation approval for PEGINTRON

Schering-Plough Corp. announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) recommended approval by a vote of six to four for PEGINTRON® (pegylated interferon alfa-2b) in the adjuvant treatment of patients with Stage III malignant melanoma.

6 Oct 2009

Bone News and Research

Shire publishes efficacy study results of FOSRENOL and Renagel

The Top 10 Medical Innovations for 2010 announced at Cleveland Clinic Medical Innovation Summit

Patients and surgeons drive demand for elective orthopedic procedures despite economic slowdown

CML Healthcare Income Fund to acquire two medical imaging operations

Galapagos receives EUR 500,000 cash payment from GSK

Daily doses of imatinib mesylate double survival rates in Ph+ ALL affected children

Research to explore diagnosis and treatment of rare diseases

NIDCR announces research and technology grants to support new Facebase Consortium

HRT may increase urinary incontinence in postmenopausal women

Scientists create new technology to improve detection of leukemia cells in bone marrow

NIH awards NeoStem a GO grant to investigate the potential of stem cells in regenerating bone

pDCs promote growth and survival of malignant myeloma cells

LMA Stonebreaker and Holmium Lasers to feature at 27th World Congress on Endourology

AAOS to participate in "Get Connected" electronic prescribing program

AAAHC accreditation for Laser Spine Institute Tampa

St. Jude Children’s Research Hospital researcher receives the Millipore Guava Flow Cytometry Award

Spinal fusion dynamic stabilization system manufacturers ordered to conduct postmarket surveillance studies

Survival rates for multivisceral transplants increase with new treatment strategies

Winner of 2009 NAMS award

Schering-Plough receives FDA recommendation approval for PEGINTRON

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News